Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.
Autor(es): Hamdalla H. H.; Hawkes C. H.; Spokes E. G.; Bamford J. M.; Goulding P. J.
Imprenta: BMJ, v. 313, n. 7069, p. 1399-1400, 1996
Identificador do objeto digital: 10.1136/bmj.313.7069.1400
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies
Data de publicação: 1996